Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations
出版年份 2019 全文链接
标题
Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations
作者
关键词
-
出版物
Nature Communications
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-06-03
DOI
10.1038/s41467-019-10363-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth
- (2018) Patrick Casara et al. Oncotarget
- MX2: a high-flux undulator microfocus beamline serving both the chemical and macromolecular crystallography communities at the Australian Synchrotron
- (2018) David Aragão et al. JOURNAL OF SYNCHROTRON RADIATION
- Ensemble Properties of Bax Determine Its Function
- (2018) Adeline Y. Robin et al. STRUCTURE
- Hierarchy for targeting prosurvival BCL2 family proteins in multiple myeloma: pivotal role of MCL1
- (2016) J.-N. Gong et al. BLOOD
- Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
- (2016) Duncan E. Scott et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
- (2016) Andrew W. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer
- (2016) Stephanie Berger et al. eLife
- α/β-Peptide Foldamers Targeting Intracellular Protein–Protein Interactions with Activity in Living Cells
- (2015) James W. Checco et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Acquired mutations in BCL2 family proteins conferring resistance to the BH3 mimetic ABT-199 in lymphoma
- (2014) V. Fresquet et al. BLOOD
- How good are my data and what is the resolution?
- (2013) Philip R. Evans et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
- (2013) Peter E. Czabotar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Role of the Acidity of N-Heteroaryl Sulfonamides as Inhibitors of Bcl-2 Family Protein–Protein Interactions
- (2013) B. Barry Touré et al. ACS Medicinal Chemistry Letters
- Identification of a phenylacylsulfonamide series of dual Bcl-2/Bcl-xL antagonists
- (2012) Heidi L. Perez et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
- (2011) Ryan D. Morin et al. NATURE
- Integration, scaling, space-group assignment and post-refinement
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX
- (2010) Bonsu Ku et al. CELL RESEARCH
- 3V: cavity, channel and cleft volume calculator and extractor
- (2010) N. R. Voss et al. NUCLEIC ACIDS RESEARCH
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
- (2009) Thomas O'Hare et al. CANCER CELL
- Conformational Changes in Bcl-2 Pro-survival Proteins Determine Their Capacity to Bind Ligands
- (2009) Erinna F. Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors
- (2008) John Porter et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
- A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation
- (2008) Erinna F. Lee et al. JOURNAL OF CELL BIOLOGY
- BCL-2 family antagonists for cancer therapy
- (2008) Guillaume Lessene et al. NATURE REVIEWS DRUG DISCOVERY
- HOLLOW: Generating Accurate Representations of Channel and Interior Surfaces in Molecular Structures
- (2008) Bosco K Ho et al. BMC STRUCTURAL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started